Effects of e-Cigarettes on Perceptions and Behavior

July 7, 2023 updated by: Adam Leventhal, University of Southern California
This project will assess the ways in which e-cigarette product diversity impacts the user experience to inform potential regulations by identifying product characteristics that may: (1) put young adults at risk for tobacco product use; and (2) facilitate adult smokers switching to e-cigarettes. There are three primary objectives to the study: (1) Determine which dimensions of e-cigarette product diversity differentially affect product appeal across young adult e-cigarette users and middle-age/older adult smokers with an interest in, but no significant experience with, e-cigarettes; (2) Determine which dimensions of e-cigarette product diversity differentially affect abuse liability in young adult e-cigarette users and the ability to resist smoking in adult smokers with an interest in, but no significant experience with, e-cigarettes; (3) Determine the affect of product characteristics on e-cigarette nicotine delivery profile. For Aim 1, young adult vapers (N=200) and adult smokers (N=200) will attend one laboratory session in which they will self-administer e-cigarette products varied according to within-subject e-cigarette factors (e.g., flavor, pg/vg ratio). For Aim 2, young adults vapers (N=360) and adult smokers (N=360) will administer an e-cigarette product and complete behavioral economic tasks that test the participant's choice of earning money to delay initiation and continued use of: (1) The sampled e-cigarette product (abuse liability; young adult vapers); or (2) Their own brand cigarettes (ability to resist smoking; adult current smokers). A pilot study will establish device and e-liquid parameters (e.g., nicotine concentration) to be used for all aims.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90033
        • University of Southern California

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Vapers

  1. E-cigarette use >3 day/week for >2 months
  2. Report regularly using e-cigarette products with nicotine
  3. Positive cotinine test via NicAlert test strip

Smokers

  1. Daily cigarette smoking for ≥ 2 years
  2. Currently smoke > 4 cig/day
  3. Interest in trying an e-cigarette or current use of e-cigarettes

Exclusion Criteria:

Vapers

  1. Pregnancy/breastfeeding
  2. Desire to immediately reduce e-cigarette use

Smokers

  1. Breath CO < 9ppm at intake
  2. Pregnancy / breastfeeding
  3. Current daily use of other combustible tobacco products (e.g., cigars)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sweet-Flavor 4.5% Nicotine (Salt)
Participants will self-administer a sweet-flavored e-cigarette containing 4.5% nicotine by volume.
Participants will self-administer an experimenter-provided e-cigarette.
Placebo Comparator: Sweet-Flavor 0 mg/mL Nicotine (Free-Base)
Participants will self-administer a sweet-flavored e-cigarette containing 0 mg/mL nicotine.
Participants will self-administer an experimenter-provided e-cigarette.
Experimental: Sweet-Flavor 6 mg/mL Nicotine (Free-Base)
Participants will self-administer a sweet-flavored e-cigarette containing 6 mg/mL nicotine.
Participants will self-administer an experimenter-provided e-cigarette.
Active Comparator: Usual e-Cigarette
Participants will self-administer either their preferred brand combustible cigarette or e-cigarette with usual nicotine nicotine concentration.
Participants will self-administer an experimenter-provided e-cigarette.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Positive Affect Negative Affect Schedule
Time Frame: 4 hours
The 10-item Positive Affect Negative Affect Schedule (PANAS-SF) will be used to measure positive and negative affect.
4 hours
Subjective Appeal
Time Frame: 1 hour
Self-report measures of product appeal will be completed following the e-cigarette administration.
1 hour
Questionnaire of Vaping Urges
Time Frame: 4 hours
10-item Brief Questionnaire of Vaping Urges will assess desire, intention, urge and need to vape e-cigarettes.
4 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adam M Leventhal, PhD, University of Southern California

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2019

Primary Completion (Actual)

March 1, 2020

Study Completion (Actual)

March 1, 2020

Study Registration Dates

First Submitted

November 14, 2018

First Submitted That Met QC Criteria

November 14, 2018

First Posted (Actual)

November 15, 2018

Study Record Updates

Last Update Posted (Actual)

July 11, 2023

Last Update Submitted That Met QC Criteria

July 7, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • HS-18-00839 - Pilot Study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Electronic Cigarettes

Clinical Trials on e-Cigarette

3
Subscribe